With the 25R1 release, Veeva Safety supports generating and submitting NMPA E2B(R3) reports to Chinese localizations. This early adopter feature includes all regional data elements to ensure compliance with National Medical Products Administration (NMPA) requirements.

After configuring this feature, see E2B Generation: NMPA E2B(R3) Mapping and Standard Agency ICSR Submissions for more information.

25R3 Update: NMPA E2B(R3): Data Model, Mapping, Validation, & Syncing Updates

With the 25R3 release, to improve NMPA E2B(R3) file generation, Veeva Safety introduces new fields and updates data mapping, validation, and syncing to Localized Cases. Although this feature is Auto-on, some components may require additional configuration.

Update the Localized Case Assessment Result Layout

Add the Localized Assessment Source field to all applicable Localized Case Assessment Result object layouts.

Update the Study Product Layout

Add the CTA Approval Numbers field to all applicable Study Product object layouts.

(25R3) Configure NMPA E2B(R3): Data Model, Mapping, Validation, & Syncing Updates

Update the following object layouts to include the latest NMPA E2B(R3) fields:

  • Add the Trade Name field to all applicable Localized Product object layouts.
  • Add the following fields to all applicable Localized Case object layouts:
    • Local MAH
    • Local New Info Date/Time
    • NMPA Report Source
  • Add the NMPA Patient Nationality Code field to the Details section of the Localized Case Contact Detail Page Layout of the Localized Case Contact object.
  • Add the following fields to all applicable Localized Case Product object layouts:
    • Additional CTA Approval Numbers
    • CTA Approval Number(s)
    • Generic Name
    • MAH Product
    • Trade Name
  • Add the NMPA Center field to all applicable Transmission Profile object layouts.